Hazlett, Burt & Watson’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13K Hold
112
﹤0.01% 651
2025
Q4
$15K Hold
112
﹤0.01% 644
2025
Q3
$10K Buy
112
+100
+833% +$9.92K ﹤0.01% 664
2025
Q2
$1K Buy
+12
New +$974 ﹤0.01% 767
2024
Q1
Sell
-53
Closed -$7K 716
2023
Q4
$7K Sell
53
-263
-83% -$30.3K ﹤0.01% 523
2023
Q3
$42K Hold
316
0.03% 323
2023
Q2
$57K Hold
316
0.04% 279
2023
Q1
$71K Hold
316
0.06% 236
2022
Q4
$61K Sell
316
-102
-24% -$21.1K 0.05% 240
2022
Q3
$78K Sell
418
-26
-6% -$5.14K 0.08% 209
2022
Q2
$79K Sell
444
-91
-17% -$23.2K 0.07% 222
2022
Q1
$182K Buy
+535
New +$181K 0.14% 146

Other funds holding ILMN

Hazlett, Burt & Watson's ILMN Position: Q1 2026 in Review

Hazlett, Burt & Watson held its Illumina (ILMN) position steady in Q1 2026 at 112 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #651.

Hazlett, Burt & Watson first reported a position in ILMN in Q1 2022 and has held it in 12 quarters since. The position peaked at $182K in Q1 2022. 845 funds tracked by Wall St. Rank hold ILMN as of Q1 2026.

  • Hazlett, Burt & Watson held 112 shares of Illumina worth $13K as of Q1 2026.
  • Hazlett, Burt & Watson left its Illumina share count unchanged in Q1 2026.
  • Illumina made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #651 holding.
  • Hazlett, Burt & Watson first reported a position in Illumina in Q1 2022 and has held it in 12 quarters since.
  • Hazlett, Burt & Watson's Illumina position peaked at $182K in Q1 2022.
  • 845 funds tracked by Wall St. Rank held Illumina as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.